MedPath

Laboratoire Boreaderme Inc.

🇨🇦Canada
Ownership
Private
Employees
-
Market Cap
-
Website

An Open Label Study to Evaluate the Safety and Efficacy of BOR15001L7 for the Treatment of Cold Sores in Patients With Recurrent Herpes Labialis

Phase 2
Conditions
Recurrent Herpes Labialis
Interventions
First Posted Date
2019-06-06
Last Posted Date
2020-09-07
Lead Sponsor
Laboratoire Boreaderme Inc.
Target Recruit Count
164
Registration Number
NCT03977792

Study of a New Topical Natural Health Product for the Treatment of Herpes Labialis

Not Applicable
Conditions
Herpes Labialis
Interventions
Other: Placebo
Other: BOR15001L7
First Posted Date
2015-10-21
Last Posted Date
2017-03-09
Lead Sponsor
Laboratoire Boreaderme Inc.
Target Recruit Count
40
Registration Number
NCT02582086
Locations
🇨🇦

Evalulab Inc, Montréal, Quebec, Canada

© Copyright 2025. All Rights Reserved by MedPath